+1 347 708 0418
Human Immunodeficiency Virus (HIV) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus (HIV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
By Company
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV) Market Perspective (2017-2028)
2.2 Human Immunodeficiency Virus (HIV) Growth Trends by Region
2.2.1 Human Immunodeficiency Virus (HIV) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Immunodeficiency Virus (HIV) Historic Market Size by Region (2017-2022)
2.2.3 Human Immunodeficiency Virus (HIV) Forecasted Market Size by Region (2023-2028)
2.3 Human Immunodeficiency Virus (HIV) Market Dynamics
2.3.1 Human Immunodeficiency Virus (HIV) Industry Trends
2.3.2 Human Immunodeficiency Virus (HIV) Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV) Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus (HIV) Players by Revenue (2017-2022)
3.1.2 Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Players (2017-2022)
3.2 Global Human Immunodeficiency Virus (HIV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Revenue
3.4 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Revenue in 2021
3.5 Human Immunodeficiency Virus (HIV) Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus (HIV) Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Type (2017-2022)
4.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2023-2028)
5 Human Immunodeficiency Virus (HIV) Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV) Historic Market Size by Application (2017-2022)
5.2 Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Market Size (2017-2028)
6.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type
6.2.1 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022)
6.2.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028)
6.2.3 North America Human Immunodeficiency Virus (HIV) Market Share by Type (2017-2028)
6.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application
6.3.1 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022)
6.3.2 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028)
6.3.3 North America Human Immunodeficiency Virus (HIV) Market Share by Application (2017-2028)
6.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country
6.4.1 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022)
6.4.2 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2017-2028)
7.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022)
7.2.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028)
7.2.3 Europe Human Immunodeficiency Virus (HIV) Market Share by Type (2017-2028)
7.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022)
7.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028)
7.3.3 Europe Human Immunodeficiency Virus (HIV) Market Share by Application (2017-2028)
7.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022)
7.4.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size (2017-2028)
8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type
8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Type (2017-2028)
8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application
8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Application (2017-2028)
8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region
8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV) Market Size (2017-2028)
9.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type
9.2.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022)
9.2.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028)
9.2.3 Latin America Human Immunodeficiency Virus (HIV) Market Share by Type (2017-2028)
9.3 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application
9.3.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022)
9.3.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028)
9.3.3 Latin America Human Immunodeficiency Virus (HIV) Market Share by Application (2017-2028)
9.4 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country
9.4.1 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022)
9.4.2 Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2017-2028)
10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type
10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Type (2017-2028)
10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application
10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Application (2017-2028)
10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country
10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Gilead Business Overview
11.1.3 Gilead Human Immunodeficiency Virus (HIV) Introduction
11.1.4 Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.1.5 Gilead Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Introduction
11.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Introduction
11.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.3.5 Johnson & Johnson Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Human Immunodeficiency Virus (HIV) Introduction
11.4.4 Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Human Immunodeficiency Virus (HIV) Introduction
11.5.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.5.5 AbbVie Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Introduction
11.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Introduction
11.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Human Immunodeficiency Virus (HIV) Introduction
11.8.4 Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.8.5 Genentech Recent Developments
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Human Immunodeficiency Virus (HIV) Introduction
11.9.4 Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022)
11.9.5 Cipla Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Human Immunodeficiency Virus (HIV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Human Immunodeficiency Virus (HIV) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2017-2022)
Table 8. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2023-2028)
Table 10. Human Immunodeficiency Virus (HIV) Market Trends
Table 11. Human Immunodeficiency Virus (HIV) Market Drivers
Table 12. Human Immunodeficiency Virus (HIV) Market Challenges
Table 13. Human Immunodeficiency Virus (HIV) Market Restraints
Table 14. Global Human Immunodeficiency Virus (HIV) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Human Immunodeficiency Virus (HIV) Revenue Share by Players (2017-2022)
Table 16. Global Top Human Immunodeficiency Virus (HIV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2021)
Table 17. Ranking of Global Top Human Immunodeficiency Virus (HIV) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Immunodeficiency Virus (HIV) Product Solution and Service
Table 21. Date of Enter into Human Immunodeficiency Virus (HIV) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2017-2022)
Table 25. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2023-2028)
Table 27. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Human Immunodeficiency Virus (HIV) Revenue Share by Application (2017-2022)
Table 29. Global Human Immunodeficiency Virus (HIV) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Human Immunodeficiency Virus (HIV) Revenue Share by Application (2023-2028)
Table 31. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2023-2028) & (US$ Million)
Table 61. Gilead Company Details
Table 62. Gilead Business Overview
Table 63. Gilead Human Immunodeficiency Virus (HIV) Product
Table 64. Gilead Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 65. Gilead Recent Developments
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product
Table 69. GlaxoSmithKline Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 70. GlaxoSmithKline Recent Developments
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product
Table 74. Johnson & Johnson Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 75. Johnson & Johnson Recent Developments
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Human Immunodeficiency Virus (HIV) Product
Table 79. Merck Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 80. Merck Recent Developments
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Human Immunodeficiency Virus (HIV) Product
Table 84. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 85. AbbVie Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product
Table 89. Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product
Table 94. Boehringer Ingelheim Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 95. Boehringer Ingelheim Recent Developments
Table 96. Genentech Company Details
Table 97. Genentech Business Overview
Table 98. Genentech Human Immunodeficiency Virus (HIV) Product
Table 99. Genentech Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 100. Genentech Recent Developments
Table 101. Cipla Company Details
Table 102. Cipla Business Overview
Table 103. Cipla Human Immunodeficiency Virus (HIV) Product
Table 104. Cipla Revenue in Human Immunodeficiency Virus (HIV) Business (2017-2022) & (US$ Million)
Table 105. Cipla Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus (HIV) Market Share by Type: 2021 VS 2028
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Homecare Settings Case Studies
Figure 9. Others Case Studies
Figure 10. Human Immunodeficiency Virus (HIV) Report Years Considered
Figure 11. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Human Immunodeficiency Virus (HIV) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Immunodeficiency Virus (HIV) Market Share by Region: 2021 VS 2028
Figure 14. Global Human Immunodeficiency Virus (HIV) Market Share by Players in 2021
Figure 15. Global Top Human Immunodeficiency Virus (HIV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2021
Figure 17. North America Human Immunodeficiency Virus (HIV) Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2017-2028)
Figure 19. North America Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2017-2028)
Figure 20. North America Human Immunodeficiency Virus (HIV) Market Size Share by Country (2017-2028)
Figure 21. United States Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Human Immunodeficiency Virus (HIV) Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2017-2028)
Figure 25. Europe Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2017-2028)
Figure 26. Europe Human Immunodeficiency Virus (HIV) Market Size Share by Country (2017-2028)
Figure 27. Germany Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Human Immunodeficiency Virus (HIV) Market Size Share by Region (2017-2028)
Figure 37. China Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Human Immunodeficiency Virus (HIV) Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Human Immunodeficiency Virus (HIV) Market Size Share by Country (2017-2028)
Figure 47. Mexico Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Share by Country (2017-2028)
Figure 53. Turkey Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Human Immunodeficiency Virus (HIV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Gilead Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 60. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 63. Genentech Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 64. Cipla Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Buy
